Cytokine Signalling Forum

Professor Nash interviews Dr Roland Grenningloh from the EMD Serono Research and Development Institute, about his paper describing the PK modelling of the novel Bruton’s tyrosine kinase (BTK) inhibitor, evobrutinib, in disease models for RA and lupus.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Tanaka and Professor Calabrese.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Josef Smolen and Professor Wenhui Xie, respectively.

Professor Nash interviews Professor Kevin Winthrop from Oregon Health Sciences University, Portland or USA, about his paper investigating pneumococcal and tetanus vaccine responses in patients with RA receiving baricitinib treatment.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Winthrop K and Professor Wollenhaupt J, respectively

Professor Nash interviews Professor Bernard Combe from the University of Montpellier, France, about a letter investigating the safety of baricitinib treatment in patients with select comorbidities.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Combe B and Dr. Zhang Z, respectively

Professor Nash interviews Professor Tsutomu Takeuchi from Keio University School of Medicine, about the paper looking at safety profile of baricitinib in Japanese patients.

Professor McInnes reviews key abstract from ACR 2018, relating to pain and JAK inhibitors.

Prof McInnes presents the monthly podcast reviewing two papers from Dr. Chengfeng Qiu and Dr. Camean-Castillo, respectively

Professor Nash interviews Professor Peter Taylor from the University of Oxford, about his paper looking at effects of baricitinib on lymphocyte subsets in rheumatoid arthritis

Prof McInnes presents the monthly podcast reviewing two papers from Prof Peter Taylor and van der Heijde, respectively

Prof McInnes presents the monthly podcast reviewing two papers from Prof Tanaka and Kivitz, respectively

Prof McInnes presents the monthly podcast reviewing two papers from Head of Clinical Pharmacology at Galapagos, Florence Namour, and Prof van Vollenhoven

Professor Nash interviews Florence Namour from Galapagos about her recent paper: Influence of Age and Renal Impairment on the Steady State Pharmacokinetics of Filgotinib, a Selective JAK1 Inhibitor

Prof McInnes presents the monthly podcast reviewing two papers from Prof van Vollenhoven and Prof Curtis

Professor Nash interviews Professor Curtis about his recent paper: Herpes zoster in Tofacitinib: Risk is Further Increased with Glucocorticoids but not Methotrexate

Dr Tracy Lovatt, Scientific Director for CESAS Medical, interviews ACR poster authors; Dr Litman, Dr Dominguez-Casas, Professor Fleischmann, Dr Mirza, Professor Taylor, Professor Kivitz and Dr Kunder.

Prof McInnes presents the monthly podcast reviewing two papers from Prof Takeuchi and Prof Smolen

Prof McInnes presents the monthly podcast reviewing two papers from Prof Kremer and Prof Taylor